EQ/T. Rowe Price Health Sciences Portfolio Class IB
| Weiss Ratings | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Reward Grade | U | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Company Info | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | AXA Equitable | |||
| Manager/Tenure (Years) | Ziad Bakri (0), Alwi Chan (0), Kenneth T. Kozlowski (0) | |||
| Website | http://www.axa-equitablefunds.com | |||
| Fund Information | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | EQ/T. Rowe Price Health Sciences Portfolio Class IB | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Oct 22, 2018 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | 0.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | -- | |||
| Dividend | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.77% | |||
| Asset Allocation | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.80% | |||
| Stock | 98.90% | |||
| U.S. Stock | 90.58% | |||
| Non-U.S. Stock | 8.32% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.18% | |||
| Convertible | 0.12% | |||
| Other Net | 0.00% | |||
| Price History | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 1.32% | |||
| 30-Day Total Return | 1.53% | |||
| 60-Day Total Return | -7.50% | |||
| 90-Day Total Return | -5.34% | |||
| Year to Date Total Return | 7.95% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| Price | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | -- | |||
| 1-Month Low NAV | $43.52 | |||
| 1-Month High NAV | $45.90 | |||
| 52-Week Low NAV | $39.67 | |||
| 52-Week Low NAV (Date) | Jan 03, 2019 | |||
| 52-Week High NAV | $47.92 | |||
| 52-Week High Price (Date) | Apr 05, 2019 | |||
| Beta / Standard Deviation | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Standard Deviation | -- | |||
| Balance Sheet | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 176.34M | |||
| Operating Ratios | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 1.20% | |||
| Turnover Ratio | 8.00% | |||
| Performance | I-37926 | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | -- | |||
| Last Bear Market Total Return | -- | |||